peritoneal cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients diagnosed with adenocarcinoma of the colon and proximal rectum and at least one of the following risk factors for PC will be considered for inclusion: * pT4 * (Resected) local peritoneal nodules in the close proximity of the primary tumour * Primary tumour presenting with obstruction and/or perforation * Positivie cytology in peritoneal lavage * Ovarian metastasis or omental metastasis;Eligibility criteria are: * age between 18 and 75 years, * ECOG performance status 0 to 2, * written informed consent obtained prior to any study specific screening procedures, * white blood cell count at least 3000/mm3, platelet count at least 100.000/mm3, * no bleeding diathesis or coagulopathy, * creatinine normal or creatinine clearance at least 50 ml/min
Exclusion criteria
Exclusion criteria: * liver and/or lung metastases, * pregnant or lactating women, * unstable or uncompensated respiratory or cardiac disease, * serious active infections, * other concurrent chemotherapy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary endpoint is hospital stay. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary endpoints are treatment related morbidity defined as surgical complications and toxicity related to the intraperitoneal chemotherapy. | — |
Countries
Netherlands